Seres Therapeutics (MCRB) PT Raised to $22 at Canaccord Genuity
Tweet Send to a Friend
(Updated - September 24, 2025 6:28 AM EDT)
Canaccord Genuity analyst John Newman raised the price target on Seres ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst John Newman raised the price target on Seres ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
